Profil
Temre Johnson is currently the Head-Investor Relations & Media Contact at Alpine Immune Sciences, Inc. Prior to this role, Mr. Johnson worked as the Director-Investor Relations & Communications at Mirati Therapeutics, Inc. from 2018 to 2022.
Postes actifs de Temre Johnson
Sociétés | Poste | Début |
---|---|---|
ALPINE IMMUNE SCIENCES, INC. | Investor Relations Contact | - |
Anciens postes connus de Temre Johnson
Sociétés | Poste | Fin |
---|---|---|
MIRATI THERAPEUTICS | Investor Relations Contact | 01/06/2022 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
ALPINE IMMUNE SCIENCES, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Mirati Therapeutics, Inc.
Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |